Market Overview

Abbott Declares $0.14/Share Qtr. Dividend, Says Spinoff AbbVie Intends Recommending $0.40/Share Dividend

Share:
Related ABT
Short Interest In Abbott Labs And Baxter International Doubles
Jefferies Updates Price Targets In Global Pharma, Sees 'Rich Catalyst Environment' Ahead
This Health Care Dividend Aristocrat Will Profit From Old Age - Globally (Seeking Alpha)

The board of directors of Abbott (NYSE: ABT) today declared its 356^th consecutive quarterly cash dividend. The quarterly dividend is $0.14 per share, payable Feb. 15, 2013, to shareholders of record on Jan. 15, 2013. The management of AbbVie, Abbott's research-based pharmaceuticals business, intends to recommend a cash dividend, subject to AbbVie board approval, of $0.40 per share, which together with Abbott's dividend will equal a cash dividend of $0.54 per share, an increase of nearly 6 percent over Abbott's quarterly cash dividend declared in September 2012.

Abbott's annualized cash dividend of $0.56 per share, combined with AbbVie's annualized cash dividend of $1.60 per share equals a total annualized cash dividend of $2.16 per share, compared to the annualized cash dividend of Abbott, prior to separation, of $2.04 per share. Future quarterly dividends, including the expected AbbVie dividend in February 2013, are subject to approval by each company's board of directors.

Posted-In: News Dividends

 

Related Articles (ABT)

View Comments and Join the Discussion!